Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center study

Invest New Drugs. 1994;12(4):345-6. doi: 10.1007/BF00873053.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Renal Cell / drug therapy*
  • Female
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Thioguanine / adverse effects
  • Thioguanine / therapeutic use*

Substances

  • Thioguanine